RNTX
Rein Therapeutics Inc
0.744$
-3.4%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 67.8% | 95.7% | 98.4% | 71.8% | 73.8% | 99.9% | 99.4% | 99.4% | 17.2% | 19.7% | 17.9% | |
| 63.4% | 94.1% | 22.5% | 35.1% | 20.1% | 43.1% | 7.4% | 23.6% | 16.3% | 18.6% | 13.3% | |
| 63.4% | 94.1% | 96.3% | 68.3% | 69.0% | 84.5% | 94.7% | 96.5% | 16.3% | 18.6% | 13.3% | |
| – | – | – | – | – | – | – | 0.0% | 6.0% | 9.1% | 26.2% | |
| – | – | – | – | – | – | – | – | 74.7% | 70.1% | 55.9% | |
| 1,687.9% | 607.7% | 9.3% | 35.3% | 39.4% | 25.6% | 9.4% | 15.4% | 93.5% | 21.4% | 30.0% | |
| 42.9% | 18.5% | 9.3% | 17.7% | 22.1% | 24.2% | 9.3% | 15.4% | 4.1% | 8.3% | 25.6% | |
| – | – | – | – | 1.7% | 1.0% | 0.2% | 0.1% | 0.0% | – | – | |
| 10.8% | 9.0% | 3.0% | 5.7% | 5.5% | 9.8% | 2.5% | 7.8% | 1.1% | 1.3% | 16.5% | |
| – | – | – | – | – | 1.3% | – | – | – | – | – | |
| -1,587.9% | -507.7% | 90.7% | 64.7% | 60.6% | 74.4% | 90.6% | 84.6% | 6.5% | 78.6% | 70.0% | |
| -1,619.8% | -519.2% | -259.9% | -555.9% | -748.4% | -1,342.0% | -506.3% | -1,239.5% | -272.2% | -507.5% | -1,661.0% | |
| – | – | – | – | – | 106.7% | 9.2% | 20.6% | 4.3% | 25.9% | 105.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.